Market Cap 16.59M
Revenue (ttm) 11.20M
Net Income (ttm) 10,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.09%
Debt to Equity Ratio 0.00
Volume 25,600
Avg Vol 55,144
Day's Range N/A - N/A
Shares Out 5.35M
Stochastic %K 2%
Beta 1.30
Analysts Strong Sell
Price Target $7.38

Company Profile

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include LPCN 1111 (TLANDO XR), a next-generation long-acting oral product candidate for TRT; LPCN 1148, a novel prodrug of testosterone and testosterone...

Industry: Biotechnology
Sector: Healthcare
Phone: 801 994 7383
Fax: 801 994 7388
Address:
675 Arapeen Drive, Suite 202, Salt Lake City, United States
mattyGLTATTFNBFOT
mattyGLTATTFNBFOT Jul. 4 at 1:14 PM
$LPCN Happy Independence Day!!! 🇺🇸 #goldenage #godshedhisgrace
0 · Reply
amazingcrwns
amazingcrwns Jul. 3 at 5:00 PM
$LPCN picked up a few more shares on this dip ahead of the 1154 investor event next week.
0 · Reply
BioAB
BioAB Jul. 2 at 8:08 PM
$LPCN added another 500
0 · Reply
BioAB
BioAB Jul. 2 at 7:03 PM
$LPCN new presentation on website. Added 500 today.
0 · Reply
BioAB
BioAB Jul. 1 at 8:53 PM
0 · Reply
FuzzBuzz
FuzzBuzz Jul. 1 at 12:19 AM
$LPCN Odds of this reaching a billion dollar marketcap in the next 3-5 years?
4 · Reply
JL_TradeZ
JL_TradeZ Jun. 29 at 5:44 PM
Final Watchlist One big earnings play. Four setups are coiling under the breakout. This week could get explosive if volume hits early. $FRSX reports earnings on July 1 and is coiled tight under 0.510 with real contracts in rail tech, NVIDIA integration, and Eye-Net investment. No dilution in 2024 or 2025. This is the only ticker on this list with a confirmed catalyst tomorrow. $ONCO has a 340K nanofloat and full EMA and VWAP stack. Nasdaq compliance win already confirmed. Needs volume for a clean break over 5.02. $BTBT insider just bought $1.5M after pivoting to Ethereum and AI GPU infrastructure. Float rotation confirmed and watching for $2.18 to trigger the squeeze. $LPCN trades under cash value with Phase 3 dosing confirmed and a virtual R&D event set for July 9. Watching $3.33 breakout into the catalyst window. $BBAI has a $384.9M backlog, biometric AI contracts at airports, and 28% short interest. $6.00 is the breakout level to watch if momentum returns. This list is stacked with real catalysts and tight technicals. FRSX is the only ticker that can run either tomorrow or Tuesday, but the rest are primed for a breakout this week. Prep early and manage size accordingly. Let's start July with some bangers 💪
4 · Reply
Orlandotrader
Orlandotrader Jun. 28 at 8:39 PM
$LPCN A No Brainer Accumulate phase as this 5 Million share ultra low float will now start the Ascent back up towards 10$ as we continue to Dose more patients. Break Thru in Oral Dosing of Postpartum Drug.
1 · Reply
BioAB
BioAB Jun. 27 at 9:13 PM
$LPCN today
0 · Reply
Ayed91
Ayed91 Jun. 27 at 1:23 PM
1 · Reply
Latest News on LPCN
Lipocine Receives Updated Regulatory Guidance on LPCN 1154

Feb 6, 2025, 8:00 AM EST - 5 months ago

Lipocine Receives Updated Regulatory Guidance on LPCN 1154


Lipocine to Present at 36th Annual Roth Conference

Mar 6, 2024, 8:00 AM EST - 1 year ago

Lipocine to Present at 36th Annual Roth Conference


Lipocine to Present at Biotech Showcase 2024

Dec 19, 2023, 8:00 AM EST - 1 year ago

Lipocine to Present at Biotech Showcase 2024


mattyGLTATTFNBFOT
mattyGLTATTFNBFOT Jul. 4 at 1:14 PM
$LPCN Happy Independence Day!!! 🇺🇸 #goldenage #godshedhisgrace
0 · Reply
amazingcrwns
amazingcrwns Jul. 3 at 5:00 PM
$LPCN picked up a few more shares on this dip ahead of the 1154 investor event next week.
0 · Reply
BioAB
BioAB Jul. 2 at 8:08 PM
$LPCN added another 500
0 · Reply
BioAB
BioAB Jul. 2 at 7:03 PM
$LPCN new presentation on website. Added 500 today.
0 · Reply
BioAB
BioAB Jul. 1 at 8:53 PM
0 · Reply
FuzzBuzz
FuzzBuzz Jul. 1 at 12:19 AM
$LPCN Odds of this reaching a billion dollar marketcap in the next 3-5 years?
4 · Reply
JL_TradeZ
JL_TradeZ Jun. 29 at 5:44 PM
Final Watchlist One big earnings play. Four setups are coiling under the breakout. This week could get explosive if volume hits early. $FRSX reports earnings on July 1 and is coiled tight under 0.510 with real contracts in rail tech, NVIDIA integration, and Eye-Net investment. No dilution in 2024 or 2025. This is the only ticker on this list with a confirmed catalyst tomorrow. $ONCO has a 340K nanofloat and full EMA and VWAP stack. Nasdaq compliance win already confirmed. Needs volume for a clean break over 5.02. $BTBT insider just bought $1.5M after pivoting to Ethereum and AI GPU infrastructure. Float rotation confirmed and watching for $2.18 to trigger the squeeze. $LPCN trades under cash value with Phase 3 dosing confirmed and a virtual R&D event set for July 9. Watching $3.33 breakout into the catalyst window. $BBAI has a $384.9M backlog, biometric AI contracts at airports, and 28% short interest. $6.00 is the breakout level to watch if momentum returns. This list is stacked with real catalysts and tight technicals. FRSX is the only ticker that can run either tomorrow or Tuesday, but the rest are primed for a breakout this week. Prep early and manage size accordingly. Let's start July with some bangers 💪
4 · Reply
Orlandotrader
Orlandotrader Jun. 28 at 8:39 PM
$LPCN A No Brainer Accumulate phase as this 5 Million share ultra low float will now start the Ascent back up towards 10$ as we continue to Dose more patients. Break Thru in Oral Dosing of Postpartum Drug.
1 · Reply
BioAB
BioAB Jun. 27 at 9:13 PM
$LPCN today
0 · Reply
Ayed91
Ayed91 Jun. 27 at 1:23 PM
1 · Reply
amazingcrwns
amazingcrwns Jun. 26 at 12:57 PM
$LPCN Glad the first patient dosing news is out, but i'm a little disappointed there wasn't more of a pop in the pre-market.
1 · Reply
JL_TradeZ
JL_TradeZ Jun. 26 at 12:42 PM
$LPCN is back on radar after dosing its first patient in a Phase 3 trial for postpartum depression. The chart is curling from oversold levels with clean support around $3.2 and momentum into the July 9 R&D update. Microfloat under 5.2M, no debt, trading under cash, and past PRs have triggered sharp moves. If volume returns, this can squeeze toward $4+
0 · Reply
RoryRoar
RoryRoar Jun. 26 at 12:39 PM
$LPCN moving up
0 · Reply
nateboyd
nateboyd Jun. 25 at 10:48 PM
$LPCN 👀🤔
0 · Reply
HetroBabadook
HetroBabadook Jun. 25 at 5:03 PM
$LPCN. ....just checking in. Is this ticker trading over 100 shares a day now???
1 · Reply
BioAB
BioAB Jun. 24 at 9:14 PM
$LPCN it switched to “recruiting” https://clinicaltrials.gov/study/NCT06979544?term=LPCN%201154&viewType=Table&rank=1&tab=history&a=2&b=3#version-content-panel
1 · Reply
brunoq14
brunoq14 Jun. 24 at 8:29 PM
$LPCN I guess the trial has started. The announcement of the July 9 BRLIZIO event refers to it as "recently initiated."
1 · Reply
BioAB
BioAB Jun. 24 at 1:28 AM
$LPCN added 500 more with these gains
0 · Reply
BioAB
BioAB Jun. 23 at 12:53 PM
$LPCN https://finance.yahoo.com/news/lipocine-host-virtual-r-d-120000354.html
0 · Reply
brunoq14
brunoq14 Jun. 23 at 10:59 AM
$LPCN Does anyone think that Lipocine might benefit from the FDA's current tendency toward the reduction of approval review times?
2 · Reply
BioAB
BioAB Jun. 20 at 8:00 PM
$LPCN bought another 1000 from these gains
0 · Reply
Geraldbeak
Geraldbeak Jun. 19 at 9:29 PM
0 · Reply